Endogenex

Endogenex is a healthcare company in Plymouth, United States, founded in 2017. It has raised $138.0M across 2 rounds, most recently a $50.0M Extension Round in March 2026.

Help Control Type 2 Diabetes – Bringing New Energy to the Treatment of Type 2 Diabetes

Employees
11–50
Founded
2017
Total Funding
$138.0M
Last Round
$50.0M Extension RoundMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Endogenex develops an investigational treatment system for people with type 2 diabetes. The company says it was founded in partnership with Mayo Clinic to change the therapeutic approach to T2D. Its Endogenex system uses precise, controlled, non-thermal pulsed electric field energy delivered endoscopically in the duodenum, with the goal of resetting metabolic signaling and helping patients control blood glucose. The system is under evaluation in clinical studies and is not for sale.

Summary

It lists 11–50 employees. It has raised $138.0M in total across 2 rounds, most recently a $50.0M Extension Round in Mar 2026. Investors include Arboretum Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries C ExtensionMar 2026
$50.0M

Sign up to see all 2 events

Funding: Series C through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Endogenex on Indexed.vc
<a href="https://indexed.vc/companies/endogenex"><img src="https://indexed.vc/api/badge/company/endogenex" alt="Endogenex on Indexed.vc" width="260" height="76" /></a>